{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:27:50Z","timestamp":1782448070208,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31300765"],"award-info":[{"award-number":["31300765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301803"],"award-info":[{"award-number":["81301803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education","doi-asserted-by":"crossref","award":["20120061120025"],"award-info":[{"award-number":["20120061120025"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jilin Province Science and Technology Development Program","award":["20130522006JH"],"award-info":[{"award-number":["20130522006JH"]}]},{"name":"National Science and Technology Major Project of the Ministry of Science and Technology of China","award":["2014ZX09304314-001"],"award-info":[{"award-number":["2014ZX09304314-001"]}]},{"name":"National Science and Technology Major Project of the Ministry of Science and Technology of China","award":["2012ZX10001009-2"],"award-info":[{"award-number":["2012ZX10001009-2"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["JCKY-QKJC03"],"award-info":[{"award-number":["JCKY-QKJC03"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.054","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T17:33:23Z","timestamp":1470332003000},"page":"4526-4535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Enhancement of fibroblast activation protein \u03b1-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice"],"prefix":"10.1016","volume":"34","author":[{"given":"Qiu","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Zhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.07.054_b0005","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/j.lungcan.2004.07.977","article-title":"Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?","volume":"45","author":"Micke","year":"2004","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.054_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gde.2009.01.003","article-title":"Cancer-associated fibroblasts and tumor growth\u2013bystanders turning into key players","volume":"19","author":"\u00d6stman","year":"2009","journal-title":"Curr Opin Genet Dev"},{"issue":"5","key":"10.1016\/j.vaccine.2016.07.054_b0015","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.054_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12263-008-0076-3","article-title":"The role of microenvironment in tumor angiogenesis","volume":"3","author":"Ribatti","year":"2008","journal-title":"Genes Nutr"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.054_b0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humpath.2005.11.020","article-title":"Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis","volume":"37","author":"Acharya","year":"2006","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.054_b0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0925-4439(97)00032-X","article-title":"Molecular cloning of seprase: a serine integral membrane protease from human melanoma","volume":"1361","author":"Goldstein","year":"1997","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Disease"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.054_b0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4161\/cbt.13.3.18696","article-title":"Fibroblast activation protein: a potential therapeutic target in cancer","volume":"13","author":"Liu","year":"2012","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.054_b0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/2326-6066.CIR-14-0002","article-title":"The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance","volume":"2","author":"Fearon","year":"2014","journal-title":"Cancer Immunol Res"},{"issue":"15","key":"10.1016\/j.vaccine.2016.07.054_b0045","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1158\/1078-0432.CCR-05-0699","article-title":"Induction of CD4+ and CD8+ T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy","volume":"11","author":"Fassnacht","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2016.07.054_b0050","first-page":"135","article-title":"Therapeutic cancer vaccines and combination immunotherapies involving vaccination","volume":"3","author":"Nguyen","year":"2014","journal-title":"ImmunoTargets Ther"},{"issue":"6005","key":"10.1016\/j.vaccine.2016.07.054_b0055","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein\u2013\u03b1","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.054_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgm.669","article-title":"DNA vaccination against tumors","volume":"7","author":"Prud\u2019homme","year":"2005","journal-title":"J Gene Med"},{"issue":"23","key":"10.1016\/j.vaccine.2016.07.054_b0065","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-05-2805","article-title":"Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts","volume":"65","author":"Lee","year":"2005","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.vaccine.2016.07.054_b0070","doi-asserted-by":"crossref","first-page":"e7965","DOI":"10.1371\/journal.pone.0007965","article-title":"Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model","volume":"4","author":"Liao","year":"2009","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2016.07.054_b0075","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI26532","article-title":"Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake","volume":"116","author":"Loeffler","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2016.07.054_b0080","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COH.0b013e32833cfe4c","article-title":"Novel adenovirus vector-based vaccines for HIV-1","volume":"5","author":"Barouch","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"10.1016\/j.vaccine.2016.07.054_b0085","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.4049\/jimmunol.1103717","article-title":"Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity","volume":"188","author":"Johnson","year":"2012","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.07.054_b0090","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s00262-012-1296-3","article-title":"DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model","volume":"61","author":"Zhang","year":"2012","journal-title":"Cancer Immunol, Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2016.07.054_b0095","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/CCO.0000000000000006","article-title":"Current status of IL-10 and regulatory T-cells in cancer","volume":"25","author":"Dennis","year":"2013","journal-title":"Curr Opin Oncol"},{"issue":"6230","key":"10.1016\/j.vaccine.2016.07.054_b0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2016.07.054_b0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00281-011-0245-0","article-title":"Immunomodulatory effects of cyclophosphamide and implementations for vaccine design","volume":"33","author":"Sistigu","year":"2011","journal-title":"Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.054_b0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1567-5769(00)00028-X","article-title":"Down regulation of T-cell-derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal lymphoproliferative response","volume":"1","author":"Matar","year":"2001","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.054_b0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CJI.0000000000000068","article-title":"Enhanced dendritic cell\u2013based immunotherapy using low-dose cyclophosphamide and CD25-targeted antibody for transplanted lewis lung carcinoma cells","volume":"38","author":"Son","year":"2015","journal-title":"J Immunother"},{"key":"10.1016\/j.vaccine.2016.07.054_b0120","doi-asserted-by":"crossref","first-page":"e85398","DOI":"10.1371\/journal.pone.0085398","article-title":"Effective chemoimmunotherapy with anti-TGF\u03b2 antibody and cyclophosphamide in a mouse model of breast cancer","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.054_b0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1479-5876-12-197","article-title":"Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice","volume":"12","author":"Hofmann","year":"2014","journal-title":"J Trans Med"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.054_b0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-3083.2011.02629.x","article-title":"Subcutaneous administration of modified vaccinia virus ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with mycobacterium tuberculosis","volume":"75","author":"You","year":"2012","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.054_b0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00262-009-0725-4","article-title":"Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma","volume":"59","author":"Lladser","year":"2010","journal-title":"Cancer Immunol, Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.054_b0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.cji.0000211329.83890.ba","article-title":"Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors","volume":"30","author":"Nagaraj","year":"2007","journal-title":"J Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.054_b0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.intimp.2013.04.015","article-title":"Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA\/MPL adjuvant in a murine melanoma model","volume":"17","author":"Wang","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2016.07.054_b0150","doi-asserted-by":"crossref","first-page":"14421","DOI":"10.1038\/srep14421","article-title":"A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2016.07.054_b0155","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/j.1349-7006.2010.01695.x","article-title":"Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model","volume":"101","author":"Wen","year":"2010","journal-title":"Cancer Sci"},{"issue":"8","key":"10.1016\/j.vaccine.2016.07.054_b0160","doi-asserted-by":"crossref","first-page":"e25961","DOI":"10.4161\/onci.25961","article-title":"Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy","volume":"2","author":"Devaud","year":"2013","journal-title":"Oncoimmunology"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2016.07.054_b0165","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.semcancer.2015.02.007","article-title":"Cancer prevention and therapy through the modulation of the tumor microenvironment","author":"Casey","year":"2015","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.054_b0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/PPO.0000000000000118","article-title":"Imaging the tumor microenvironment","volume":"21","author":"LeBleu","year":"2015","journal-title":"Cancer J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:42:33Z","timestamp":1589683353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":34,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X16306521"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of fibroblast activation protein \u03b1-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}